EFFECT OF PHORBOL ESTER AND CYTOKINES ON MATRIX METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE EXPRESSION IN TUMOR AND NORMAL-CELL LINES

被引:0
|
作者
MACKAY, AR [1 ]
BALLIN, M [1 ]
PELINA, MD [1 ]
FARINA, AR [1 ]
NASON, AM [1 ]
HARTZLER, JL [1 ]
THORGEIRSSON, UP [1 ]
机构
[1] SPERIMENTALE COLLEMAGGIO,DIPARTIMENTO MED,LAQUILA,ITALY
来源
INVASION & METASTASIS | 1992年 / 12卷 / 3-4期
关键词
12-O-TETRADECANOYLPHORBOL-13-ACETATE; INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA; MATRIX METALLOPROTEINASES; METALLOPROTEINASE INHIBITORS; AP-1-BINDING PROTEIN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and the cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) on matrix metalloproteinases (MMP) and metalloproteinase inhibitors was studied in a variety of human cell lines. Expression of the mammalian collagenase (MMP-1), 72-kD gelatinase/type IV collagenase (MMP-2), stromelysin (MMP-3), 92-kD getatinase/type IV collagenase (MMP-9), and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) was assessed by zymography and Northern blot analysis. MMP-2 and TIMP-2 activities were refractory to TPA, IL-1 and TNF-alpha treatment in most of the cell lines. In contrast, MMP-3, MMP-9 and TIMP-1 activities were markedly stimulated by TPA in most of the tumor cell lines and human umbilical vein endothelial cells (HUVEC), whereas the fibroblast lines were minimally stimulated or unresponsive to TPA. The MMP-3, MMP-9 and TIMP-1 stimulation in response to IL-1 and TNF-alpha treatment was detected in some of the tumor cell lines and HUVEC. The increase in activity was less marked than in TPA. A breast carcinoma cell line, MDA-MB-231, which did not express MMP-2, had high expression of MMP-3 and MMP-9 which were unaffected bv TPA and cytokine treatment. Northern blot analysis of MMP and TIMP mRNA expression reflected the zymogram findings for most of the cell lines. TPA-mediated stimulation of MMP-1 was similar to that of MMP-3 and MMP-9. Exceptions were the fibroblast cell lines which showed either a much more marked mRNA response of MMP-9 to TPA than observed at protein level, or a high constitutive MMP-9 mRNA when MMP-9 activity was not detectable by zymography. TPA-mediated stimulation of MMP-9 and TIMP-1 activity was blocked by staurosporine, an inhibitor of protein kinase C (PKC). A non-PKC-activating phorbol ester, 4alpha-phorbol-12,13-didecanoate, did not stimulate MMP-9 and TIMP-1 activity. TPA treatment caused the increased expression of c-fos containing AP-1-specific binding activity in selected tumor cell lines. This activity was maximal at 6 h. An association was observed between AP-1 binding activity and increased expression of MMP-1, MMP-3 and MMP-9. which possess TPA-responsive elements (TRE). TPA-sensitive MMPs and TIMP-1 were variably stimulated by biologically relevant cytokines, such as IL-1 and TNF-alpha. TNF-alpha mediated an increase in MMP-9, but not TIMP-1 activity, in a lung carcinoma cell line (A-549). This suggests that cytokines may cause an imbalance in metalloproteinase and TIMP secretion by tumor cells in certain cases, which would favor extracellular matrix degradation. These data from a variety of normal and human tumor cell lines suggest that MMP-2 and TIMP-2 are regulated differently from MMP-1, MMP-3, MMP-9 and TIMP-1 by activators of PKC.
引用
收藏
页码:168 / 184
页数:17
相关论文
共 50 条
  • [1] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [2] Expression of matrix metalloproteinase, a disintegrin and metalloproteinase, and tissue inhibitor of metalloproteinase in human chondrosarcoma
    Sugita, H
    Osaka, S
    Toriyama, M
    Osaka, E
    Yoshida, Y
    Ryu, J
    Sano, M
    Sugitani, M
    Nemoto, N
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2004, 37 (05) : 319 - 323
  • [3] The effect of some cytokines on production of tissue inhibitor of metalloproteinase-2 by choriocarcinoma cell lines
    Ozornek, M. H.
    Koldovsky, U.
    HUMAN REPRODUCTION, 2001, 16 : 157 - 157
  • [4] Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines
    Maquoi, E
    Frankenne, F
    Baramova, E
    Munaut, C
    Sounni, NE
    Remacle, A
    Noël, A
    Murphy, G
    Foidar, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) : 11368 - 11378
  • [5] Matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in diabetic and venous ulcers
    Jude, EB
    Rogers, AA
    Oyibo, SO
    Armstrong, DG
    Boulton, AJM
    DIABETOLOGIA, 2001, 44 : A3 - A3
  • [6] REGULATION OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE EXPRESSION
    OVERALL, CM
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 51 - 64
  • [7] Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma
    Yukiue, H
    Sasaki, H
    Kobayashi, Y
    Nakashima, Y
    Moriyama, S
    Yano, M
    Kaji, M
    Kiriyama, M
    Fukai, I
    Yamakawa, Y
    Fujii, Y
    JOURNAL OF SURGICAL RESEARCH, 2003, 109 (02) : 86 - 91
  • [8] Modulation of metalloproteinase expression in trophoblast cell lines by cytokines
    Morgan, M
    McDonnell, S
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (01) : S52 - S52
  • [9] Human thyroid carcinoma cell lines and normal thyrocytes: Expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein
    Aust, G
    Hofmann, A
    Laue, S
    Rost, A
    Kohler, T
    Scherbaum, WA
    THYROID, 1997, 7 (05) : 713 - 724
  • [10] Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
    Pagenstecher, A
    Stalder, AK
    Kincaid, CL
    Shapiro, SD
    Campbell, IL
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 152 (03): : 729 - 741